Prohledat tento blog

Different subtypes of carcinoma in situ of the bladder do not have a different prognosis | DocGuide

Different subtypes of carcinoma in situ of the bladder do not have a different prognosis | DocGuide

Pathologists need not include different subtypes of primary CIS in their report as there is no difference in patient outcomes. It is important to recognize all different subtypes as CIS for best patient treatment.
Enhanced by Zemanta

Žádné komentáře:

Okomentovat

Sulfated polysaccharide of Sepiella maindroni ink targets Akt and overcomes resistance to the FGFR inhibitor AZD4547 in bladder cancer

článek zde  Shan L, Liu W, Zhan Y. Sulfated polysaccharide of  Sepiella maindroni  ink targets Akt and overcomes resistance to the FGFR in...